HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

Skf 77434

HCID 1241
NotesReactions
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
104422-04-0
Standard SMILES
C=CCN1CCc2cc(O)c(O)cc2C(c2ccccc2)C1
InChIKey
QBUVZVXIRYFENV-UHFFFAOYSA-N
Molecular formula
C19H21NO2
Average molar mass
295.4 g/mol
Monoisotopic mass
295.15722891

Overview

N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol is a benzazepine that is 2,3,4,5-tetrahydro-3-benzazepine bearing a phenyl substituent at position 1, an allyl substituent at position 3 and two hydroxy substituents at positions 7 and 8. Selective dopamine D1-like receptor partial agonist (IC50 values are 19.7 and 2425 nM for binding to D1-like and D2-like receptors respectively). Centrally active following systemic administration in vivo. It has a role as a dopamine agonist. It is a member of catechols, a benzazepine and a tertiary amino compound. It is a conjugate base of a N-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepinium-7,8-diol(1+).

Names & identifiers

Preferred name
Skf 77434
IUPAC
5-phenyl-3-prop-2-enyl-1,2,4,5-tetrahydro-3-benzazepine-7,8-diol
English name
(+/-)-7,8-Dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrobromide
Molecular formula
C19H21NO2
Molecular weight
295.38

Names & synonyms

104422-04-0Skf-77434SKF 77434SK&F 77434XA99M7XZR5J247.964HDTXSID30438171H-3-Benzazepine-7,8-diol, 2,3,4,5-tetrahydro-1-phenyl-3-(2-propenyl)-1H-3-Benzazepine-7,8-diol, 2,3,4,5-tetrahydro-1-phenyl-3-(2-propen-1-yl)-SKF-77,434RefChem:183297DTXCID1023817
Show more names
sk&f77434SKF 77434 HYDROBROMIDE(+/-)-SKF-77434 HYDROBROMIDE(+/-)-N-ALLYL-SKF-38393 HYDROBROMIDE(+/-)-SKF-38393, N-ALLYL-, HYDROBROMIDE(+)-SKF-38393, N-ALLYL-, HYDROBROMIDE D1 DOPAMINE AGONIST2,3,4,5-Tetrahydro-1-phenyl-3-(2-propenyl)-1H-3-benzazepine-7,8-diol2,3,4,5-TETRAHYDRO-1-PHENYL-3-(2-PROPENYL)-1H-3-BENZAZEPINE-7,8-DIOL HYDROBROMIDE
(A+-)-SKF-774343-Allyl-2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine5-phenyl-3-prop-2-enyl-1,2,4,5-tetrahydro-3-benzazepine-7,8-diol1H-3-Benzazepine-7,8-diol,2,3,4,5-tetrahydro-1-phenyl-3-(2-propen-1-yl)-CHEMBL2880903-allyl-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine-7,8-diol(+/-)-7,8-Dihydroxy-3-allyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrobromideN-allyl-1-phenyl-2,3,4,5-tetrahydro-3-benzazepine-7,8-diol

Properties

Computed structural properties

XLogP
3.6
Topological polar surface area
43.7 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
3
Rotatable bonds
3
Heavy atoms
22
Formal charge
0
Complexity
366

Physicochemical properties

Boiling point
470.406 · 470.406±45.00 °C(Press: 760.00 Torr)(predicted)
Density
1.157 · 1.157±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
storage temp.
2 · 2-8°C
solubility
3.2 mg/mL · ethanol: 3.2 mg/mL
form
solid
pka
10.186 · 10.186±0.40(predicted)
color
white or off-white
FDA UNII
99 M7XZR5 · XA99M7XZR5
WGK Germany
3 · 3

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

wgk
3

Chemistry & industry

Pharmacology

MeSH Pharmacological ClassificationDrugs that bind to and activate dopamine receptors.

Applications

UsesN-Allyl-(+/-)-SKF-38393 hydrobromide is a selective dopamine D1-like receptor partial agonist.

Suppliers2 total

武汉易泰科技有限公司上海分公司18930552037 · [email protected]
EMMX Biotechnology LLC888-539-0666 · [email protected]
Additional notes · 1 item

DefinitionChEBI: A benzazepine that is 2,3,4,5-tetrahydro-3-benzazepine bearing a phenyl substituent at position 1, an allyl substituent at position 3 and two hydroxy substituents at positions 7 and 8. Selective dopamine D1-like receptor partial agonist (IC50 values are 19 7 and 2425 nM for binding to D1-like and D2-like receptors respectively). Centrally active following systemic administration in vivo.

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
104422-04-0
PubChem CID
1241
DTXSID
DTXSID3043817
ChEMBL
CHEMBL288090
ChEBI
CHEBI:63988
UNII
XA99M7XZR5
Nikkaji
J247.964H